BRUNELLO, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 10.026
EU - Europa 5.521
AS - Asia 1.061
OC - Oceania 24
SA - Sud America 23
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.673
Nazione #
US - Stati Uniti d'America 9.953
GB - Regno Unito 1.558
DE - Germania 1.447
IT - Italia 864
SE - Svezia 628
CN - Cina 365
HK - Hong Kong 344
RU - Federazione Russa 212
UA - Ucraina 210
BG - Bulgaria 167
FI - Finlandia 141
TR - Turchia 140
FR - Francia 85
IE - Irlanda 80
IN - India 64
SG - Singapore 61
CA - Canada 56
BE - Belgio 24
AU - Australia 22
CH - Svizzera 18
ES - Italia 16
RO - Romania 16
JP - Giappone 14
BR - Brasile 12
MX - Messico 12
PL - Polonia 12
VN - Vietnam 12
NL - Olanda 10
IR - Iran 8
DK - Danimarca 6
EG - Egitto 6
KR - Corea 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CL - Cile 5
ID - Indonesia 5
IL - Israele 5
PK - Pakistan 5
TH - Thailandia 5
AR - Argentina 4
GR - Grecia 4
MY - Malesia 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CZ - Repubblica Ceca 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
MD - Moldavia 3
AN - Antille olandesi 2
BZ - Belize 2
IQ - Iraq 2
LT - Lituania 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
BD - Bangladesh 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
HT - Haiti 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
SD - Sudan 1
Totale 16.673
Città #
Fairfield 1.579
Southend 1.265
Chandler 1.038
Woodbridge 831
Ashburn 794
Houston 646
Wilmington 539
Cambridge 484
Seattle 450
Jacksonville 430
Nyköping 407
Hong Kong 330
Dearborn 326
Ann Arbor 322
Modena 267
San Diego 216
Princeton 187
Sofia 167
Beijing 139
Dublin 78
Eugene 77
Helsinki 74
New York 73
Izmir 67
London 62
Des Moines 57
Falls Church 48
Fremont 45
Redwood City 41
Milan 37
Norwalk 37
Shanghai 29
Bremen 27
Rome 25
Bologna 23
San Mateo 23
Brussels 21
Kilburn 20
Parma 20
Hounslow 19
Catania 18
Nanjing 18
Toronto 18
Boardman 15
Reggio Emilia 14
Hefei 13
Chiswick 12
San Giuliano Milanese 12
Chicago 10
Ottawa 10
San Francisco 10
Vancouver 10
Verona 10
Dong Ket 9
Kunming 9
Liebefeld 9
Sydney 9
Auburn Hills 8
Guangzhou 8
Phoenix 8
Prescot 8
Bari 7
Central District 7
Indiana 7
Istanbul 7
Leawood 7
Paris 7
Augusta 6
Florence 6
Los Angeles 6
Paderno Dugnano 6
Tappahannock 6
Zhengzhou 6
Ardabil 5
Chengdu 5
Dongguan 5
Frankfurt am Main 5
Iasi 5
Jinan 5
Konya 5
Leicester 5
Madrid 5
Mexico City 5
Mumbai 5
Priverno 5
Tokyo 5
Amsterdam 4
Brembate di Sopra 4
Brescia 4
Buffalo 4
Chennai 4
Clearwater 4
Como 4
Fuzhou 4
Hebei 4
Islington 4
Kemerovo 4
Maser 4
Mountain View 4
New Haven 4
Totale 11.757
Nome #
Disease-induced neuroinflammation and depression 288
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons. 286
Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment 264
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 257
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 242
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 228
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in a rat model of depression 227
Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 226
P.2.a.012 Co-administration of fluoxetine with acetylsalicylic acid, but not flurbiprofen or celecoxib, for one week shows an antidepressant-like effect 225
Hypothalamic expression of inflammatory mediators in an animal model of binge eating 223
Interferon alpha exposure increases the expression of the enzymes belonging to the kynurenine pathway in an in vitro model of human neurons: SH-SY5Y cells 219
Molecular changes associated with escitalopram response in a stress-based model of depression 218
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells 217
Erratum to: Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 (J Neuroimmune Pharmacol, 2015, DOI 10.1007/s11481-015-9641-x) 216
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 215
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 214
Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus 211
Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression 210
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment 209
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 206
Neonatal persistent inflammation alters pain response and NMDA receptor expression in adult mice 204
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression 201
Lymnaea stagnalis as model for translational neuroscience research: from pond to bench 201
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 200
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 199
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. 196
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 195
Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. 188
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 188
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study 183
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 182
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 181
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depression 177
HTR1B as a risk profile maker in psychiatric disorders:a review through motivation and memory 173
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases 172
Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure 171
Behavioural and molecular effects of the combined treatment fluoxetine plus acetylsalicylic acid in a rat model of depression 171
Early postnatal chronic inflammation produces long-term changes in pain behavior and N-methyl-D-aspartate receptor subtype gene expression in the central nervous system of adult mice 170
Modulation of neuroplasticity-related targets following stress-induced acute escape deficit 170
Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders 169
Cloning of mouse Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKKbeta) and characterization of CaMKKbeta and CaMKKalpha distribution in the adult mouse brain. 166
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 165
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 162
Regulation of CREB function in rat frontal cortex after combined treatment with Fluoxetine and Olanzapine 161
Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK alpha and CaMKK beta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor 160
Interferon-alpha exposure increases the expression of enzymes of the kynurenine pathway and induces apoptosis in a model of human neurons 158
Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression 158
Mood stabilizers: protecting the mood ... protecting the brain 156
Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain 155
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 155
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 155
Gene expression profile of the hippocampus of a behavioural model of depression 153
New combination therapies from animal to human 151
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 147
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 142
Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressio 141
Restraint stress increases the expression of brain derived neurotrophic factor in the hippocampus of a mouse model of depression 141
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas 141
Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). . 137
Cyclic GMP inhibition of metabotropic glutamate receptor-induced phosphoinositide hydrolysis in mesencephalic neurons 135
Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus 131
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression 130
Metabolic characterization of SH-SY5Y cells and effects of interferon-alpha exposure 129
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment 128
Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression 128
Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade 128
cAMP-dependent phosphorylation system after short and long-term administration of moclobemide 126
Practical issues in clinical research of schizophrenia 125
Metabolic changes induced by interferon-α exposure in an in vitro model of human neurons 125
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats 122
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment 121
Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress 116
Chiralità e farmaci antidepressivi 110
Escitalopram: meccanismo d’azione e profili clinico 108
Deciphering the central immunomodulatory effects of a vortioxetine pretreatment on the LPS-induced inflammatory cascade 106
Serum metabolic signature of binge-like palatable food consumption in female rats by nuclear magnetic resonance spectroscopy 104
New insights into the biology of schizophrenia through the mechanism of action of clozapine. 100
Second messenger-regulated protein kinases in the brain: Their functional role and the action of antidepressant drugs 95
Hippocampus-related effects of fluoxetine treatment under stressful vs enriched conditions 93
P.304 Executive functioning and genetic variation in pediatric patients with cancer 86
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit NMDA receptor activity and prevent neurotoxicity in mesencephalic neuron in vitro 81
Environmental enrichment influences mouse hippocampal neuroinflammatory response 72
Farmacologia e neurobiologia nei disturbi d'ansia e nella depressione 71
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 59
ADOLESCENCE AS A CRITICAL TIME-WINDOW FOR NEUROINFLAMMATION IN THE MOUSE: WHY SEX MATTERS 55
BIOCHEMICAL AND MOLECULAR CHANGES IN RAT CEREBRAL CORTEX AFTER CHRONIC ANTIDEPRESSANT TREATMENT: ‘IN VITRO AND’‘IN VIVO’ STUDIES 55
Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice 54
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: Dissociation from effects on prolactin secretion 52
Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the δ‐opiate antagonist ICI 154129 51
Age‐Related Changes in Rat Serotonergic and Adrenergic Systems and in Receptor Responsiveness to Subchronic Desipramine Treatment 51
Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: Interactions with reserpine 50
Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies 50
Posttraumatic stress disorder: Diagnosis and epidemiology, comorbidity and social consequences, biology and treatment 50
Effects of an extract of Ginkgo Biloba on noradrenergic systems of rat cerebral cortex 49
cAMP-dependent binding proteins and endogenous phosphorylation after antidepressant treatment 49
The activity of some neurotransmitter-synthetizing enzymes in experimental cobalt epilepsy 48
cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity 46
Role of dopamine D3 receptors, dysbindin, and their functional interaction on the expression of key genes for neuroplasticity in the mouse brain 45
Age-related changes in 5HT uptake and [3H]imipramine binding sites in rat cerebral cortex 45
Identification and characterization of the kynurenine pathway in the pond snail Lymnaea stagnalis 44
Totale 14.719
Categoria #
all - tutte 77.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019954 0 0 0 0 0 0 0 0 0 179 385 390
2019/20202.978 233 166 88 138 293 457 484 323 272 96 268 160
2020/20212.841 411 88 241 263 279 232 205 288 174 311 218 131
2021/20223.346 478 258 153 241 75 233 113 137 307 351 686 314
2022/20232.866 303 255 250 293 289 441 43 307 424 28 116 117
2023/20241.594 130 127 130 222 379 157 101 278 38 32 0 0
Totale 16.991